由ATP控制的瘤细胞特异信号处理平台,用于非侵入性调节细胞行为
Guofang Zhang1, Shuzhen Yue2, Hongyan Geng3
1Department of Obstetrics and Gynecology, The Affiliated Hospital of Qingdao University, Qingdao University, Qingdao 266000, P. R. China.
Nano letters
|November 11, 2024
概括
我们开发了一种针对瘤细胞的特定平台来控制膜受体活性,从而能够精确调节细胞行为,如潜在的癌症治疗的迁移和入侵.
科学领域:
- 生物医学工程 生物医学工程
- 分子生物学分子生物学
- 癌症研究 癌症研究
背景情况:
- 膜受体的空间分布对于细胞功能至关重要.
- 细胞行为失调有助于生理和病理过程,包括癌症.
研究的目的:
- 构建一个针对瘤细胞的特定信号处理平台 (TCS-SPP).
- 通过控制c-Met受体二元化来非侵入性调节细胞行为.
- 探索向癌症治疗和生物医学工程中的应用.
主要方法:
- 利用双胺体识别系统进行向癌细胞歧视.
- 采用了带膜固的DNA信号处理器 (DSP) 与滚动圆放大器 (RCA) 进行信号放大.
- 包含一个ATP分子开关用于信号转换以调节下游受体活动.
主要成果:
- 该TCS-SPP成功地区分了向癌细胞和处理信号.
- 证明了细胞行为的准确调节,包括细胞迁移,入侵和增殖.
- 该平台的设计,包括DSP刚性和RCA产品效果,提高了性能.
结论:
- TCS-SPP提供了一种用于非侵入性调节细胞行为的新策略.
- 这个平台显示了针对性癌症治疗和先进的生物医学工程应用的巨大潜力.
相关概念视频
mTOR Signaling and Cancer Progression
3.7K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.7K
PI3K/mTOR/AKT Signaling Pathway
3.4K
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...
3.4K
Targeted Cancer Therapies
7.5K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.5K
Amplifying Signals via Enzymatic Cascade
8.3K
When a ligand binds to a cell-surface receptor, the receptor's intracellular domain changes shape, which may either activate its enzyme function or allow its binding to other molecules. The initial signal is amplified by most signal transduction pathways. This means that a single ligand molecule can activate multiple molecules of a downstream target. Proteins that relay a signal are most commonly phosphorylated at one or more sites, activating or inactivating the protein. Kinases catalyze...
8.3K
Interactions Between Signaling Pathways
6.2K
Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
6.2K
Adaptive Mechanisms in Cancer Cells
5.7K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
5.7K


